{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:49:08Z","timestamp":1791805748268,"version":"4.3.4"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Identification of molecular aberrations in premalignant human mammary epithelial cells (hMEC), the precursors for breast cancers, is a central goal in breast cancer biology. Recent studies implicated expression of cyclooxygenase 2 (COX-2) as a marker to identify precursor cells for breast cancer. In this study, we analyzed COX-2 expression in preselection and postselection hMEC cells and observed similar COX-2 levels in both cells. Interestingly, immortalization of postselection cells using various methods leads to a dramatic decrease in COX-2 expression. Similar to immortal cells, the majority of breast cancer cell lines expressed low levels of COX-2 protein. Finally, analyses of COX-2 expression in a series of specimens from reduction mammoplasty, adenosis, ductal carcinoma in situ, and infiltrating ductal carcinoma showed down-regulation of COX-2 expression during tumor progression. Importantly, down-regulation of COX-2 using small interfering RNA in cells showed no effect on cell proliferation, anchorage-independent growth, migration, or invasion. These results show that (a) COX-2 overexpression does not seem to predict a breast cancer precursor cell and does not provide advantage for the cell to be transformed; (b) inhibition of COX-2 does not affect hMEC growth and oncogenic behavior in the conditions analyzed; and (c) COX-2 expression is decreased in breast cancer cell lines and cancer specimens as compared with normal mammary epithelial cells. [Cancer Res 2008;68(2):467\u201375]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-0782","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T23:08:10Z","timestamp":1200438490000},"page":"467-475","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cyclooxygenase-2 Expression during Immortalization and Breast Cancer Progression"],"prefix":"10.1158","volume":"68","author":[{"given":"Xiangshan","family":"Zhao","sequence":"first","affiliation":[{"name":"1Cancer Biology and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Goswami","sequence":"additional","affiliation":[{"name":"1Cancer Biology and Divisions of"},{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Pokhriyal","sequence":"additional","affiliation":[{"name":"1Cancer Biology and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ma","sequence":"additional","affiliation":[{"name":"1Cancer Biology and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Du","sequence":"additional","affiliation":[{"name":"4Center for Outcome Research and Education, Evanston Northwestern Healthcare Research Institute and Feinberg School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[{"name":"6Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Victor","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Polyak","sequence":"additional","affiliation":[{"name":"6Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Sturgis","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Band","sequence":"additional","affiliation":[{"name":"2Molecular Oncology, Department of Medicine,"},{"name":"5Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimla","family":"Band","sequence":"additional","affiliation":[{"name":"1Cancer Biology and Divisions of"},{"name":"5Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,1,15]]},"reference":[{"key":"2022061700270092200_B1","doi-asserted-by":"crossref","unstructured":"Coradini D, Daidone MG. Biomolecular prognostic factors in breast cancer. Curr Opin Obstet Gynecol\u20082004; 16: 49\u20135.","DOI":"10.1097\/00001703-200402000-00010"},{"key":"2022061700270092200_B2","doi-asserted-by":"crossref","unstructured":"Dimri G, Band H, Band V. Mammary epithelial cell transformation: insights from cell culture and mouse models. Breast Cancer Res\u20082005; 7: 171\u20139.","DOI":"10.1186\/bcr1275"},{"key":"2022061700270092200_B3","unstructured":"Foster SA, Galloway DA. Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene\u20081996; 12: 1773\u20139."},{"key":"2022061700270092200_B4","doi-asserted-by":"crossref","unstructured":"Ethier SP, Summerfelt RM, Cundiff KC, Asch BB. The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res Treat\u20081991; 17: 221\u201330.","DOI":"10.1007\/BF01806371"},{"key":"2022061700270092200_B5","doi-asserted-by":"crossref","unstructured":"Yaswen P, Stampfer MR. Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells. Int J Biochem Cell Biol\u20082002; 34: 1382\u201394.","DOI":"10.1016\/S1357-2725(02)00047-X"},{"key":"2022061700270092200_B6","doi-asserted-by":"crossref","unstructured":"Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD. Normalhuman mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature\u20082001; 409: 633\u20137.","DOI":"10.1038\/35054579"},{"key":"2022061700270092200_B7","unstructured":"Huschtscha LI, Noble JR, Neumann AA, et al. Loss of p16INK4 expression by methylation is associated with life span extension of human mammary epithelial cells. Cancer Res\u20081998; 58: 3508\u201312."},{"key":"2022061700270092200_B8","doi-asserted-by":"crossref","unstructured":"Crawford YG, Gauthier ML, Joubel A, et al. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell\u20082004; 5: 263\u201373.","DOI":"10.1016\/S1535-6108(04)00023-6"},{"key":"2022061700270092200_B9","unstructured":"Shim V, Gauthier ML, Sudilovsky D, et al. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium. Cancer Res\u20082003; 63: 2347\u201350."},{"key":"2022061700270092200_B10","doi-asserted-by":"crossref","unstructured":"Spizzo G, Gastl G, Wolf D, et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. Br J Cancer\u20082003; 88: 574\u20138.","DOI":"10.1038\/sj.bjc.6600741"},{"key":"2022061700270092200_B11","unstructured":"Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res\u20082002; 62: 632\u20135."},{"key":"2022061700270092200_B12","unstructured":"Davies G, Salter J, Hills M, Martin LA, Sacks N, Dowsett M. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clin Cancer Res\u20082003; 9: 2651\u20136."},{"key":"2022061700270092200_B13","doi-asserted-by":"crossref","unstructured":"Boland GP, Butt IS, Prasad R, Knox WF, Bundred NJ. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer\u20082004; 90: 423\u20139.","DOI":"10.1038\/sj.bjc.6601534"},{"key":"2022061700270092200_B14","doi-asserted-by":"crossref","unstructured":"Witton CJ, Hawe SJ, Cooke TG, Bartlett JM. Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology\u20082004; 45: 47\u201354.","DOI":"10.1111\/j.1365-2559.2004.01898.x"},{"key":"2022061700270092200_B15","doi-asserted-by":"crossref","unstructured":"Gislason GH, Jacobsen S, Rasmussen JN, et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation\u20082006; 113: 2906\u201313.","DOI":"10.1161\/CIRCULATIONAHA.106.616219"},{"key":"2022061700270092200_B16","doi-asserted-by":"crossref","unstructured":"Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer\u20082001; 8: 97\u2013114.","DOI":"10.1677\/erc.0.0080097"},{"key":"2022061700270092200_B17","doi-asserted-by":"crossref","unstructured":"Band V, Zajchowski D, Kulesa V, Sager R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A\u20081990; 87: 463\u20137.","DOI":"10.1073\/pnas.87.1.463"},{"key":"2022061700270092200_B18","unstructured":"Band V, Zajchowski D, Swisshelm K, et al. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res\u20081990; 50: 7351\u20137."},{"key":"2022061700270092200_B19","doi-asserted-by":"crossref","unstructured":"Wazer DE, Liu XL, Chu Q, Gao Q, Band V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci U S A\u20081995; 92: 3687\u201391.","DOI":"10.1073\/pnas.92.9.3687"},{"key":"2022061700270092200_B20","doi-asserted-by":"crossref","unstructured":"Ratsch SB, Gao Q, Srinivasan S, Wazer DE, Band V. Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells. Radiat Res\u20082001; 155: 143\u201350.","DOI":"10.1667\/0033-7587(2001)155[0143:MGCARF]2.0.CO;2"},{"key":"2022061700270092200_B21","doi-asserted-by":"crossref","unstructured":"Hu M, Yao J, Cai L, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet\u20082005; 37: 899\u2013905.","DOI":"10.1038\/ng1596"},{"key":"2022061700270092200_B22","doi-asserted-by":"crossref","unstructured":"Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol\u20082002; 30: 503\u201312.","DOI":"10.1016\/S0301-472X(02)00806-8"},{"key":"2022061700270092200_B23","doi-asserted-by":"crossref","unstructured":"Band V. In vitro models of early neoplastic transformation of human mammary epithelial cells. Methods Mol Biol\u20082003; 223: 237\u201348.","DOI":"10.1385\/1-59259-329-1:237"},{"key":"2022061700270092200_B24","doi-asserted-by":"crossref","unstructured":"Stampfer MR, Bartley JC. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci U S A\u20081985; 82: 2394\u20138.","DOI":"10.1073\/pnas.82.8.2394"},{"key":"2022061700270092200_B25","doi-asserted-by":"crossref","unstructured":"Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res\u20082005; 65: 2234\u201342.","DOI":"10.1158\/0008.5472.CAN-04-2781"},{"key":"2022061700270092200_B26","doi-asserted-by":"crossref","unstructured":"Song X, Lin HP, Johnson AJ, et al. Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells. J Natl Cancer Inst\u20082002; 94: 585\u201391.","DOI":"10.1093\/jnci\/94.8.585"},{"key":"2022061700270092200_B27","doi-asserted-by":"crossref","unstructured":"Kashfi K, Rigas B. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention. Biochem Pharmacol\u20082005; 70: 969\u201386.","DOI":"10.1016\/j.bcp.2005.05.004"},{"key":"2022061700270092200_B28","doi-asserted-by":"crossref","unstructured":"Band V. Preneoplastic transformation of human mammary epithelial cells. Semin Cancer Biol\u20081995; 6: 185\u201392.","DOI":"10.1006\/scbi.1995.0015"},{"key":"2022061700270092200_B29","doi-asserted-by":"crossref","unstructured":"Stampfer MR, Yaswen P. Culture models of human mammary epithelial cell transformation. J Mammary Gland Biol Neoplasia\u20082000; 5: 365\u201378.","DOI":"10.1023\/A:1009525827514"},{"key":"2022061700270092200_B30","unstructured":"Holst CR, Nuovo GJ, Esteller M, et al. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res\u20082003; 63: 1596\u2013601."},{"key":"2022061700270092200_B31","doi-asserted-by":"crossref","unstructured":"Wazer DE, Chu Q, Liu XL, Gao Q, Safaii H, Band V. Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Mol Cell Biol\u20081994; 14: 2468\u201378.","DOI":"10.1128\/MCB.14.4.2468"},{"key":"2022061700270092200_B32","doi-asserted-by":"crossref","unstructured":"Toouli CD, Huschtscha LI, Neumann AA, et al. Comparison of human mammary epithelial cells immortalized by simian virus 40 T-antigen or by the telomerase catalytic subunit. Oncogene\u20082002; 21: 128\u201339.","DOI":"10.1038\/sj.onc.1205014"},{"key":"2022061700270092200_B33","unstructured":"Cao Y, Gao Q, Wazer DE, Band V. Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells. Cancer Res\u20081997; 57: 5584\u20139."},{"key":"2022061700270092200_B34","unstructured":"Dimri GP, Martinez JL, Jacobs JJ, et al. Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res\u20082002; 62: 4736\u201345."},{"key":"2022061700270092200_B35","unstructured":"Nonet GH, Stampfer MR, Chin K, Gray JW, Collins CC, Yaswen P. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res\u20082001; 61: 1250\u20134."},{"key":"2022061700270092200_B36","doi-asserted-by":"crossref","unstructured":"Foster SA, Wong DJ, Barrett MT, Galloway DA. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol\u20081998; 18: 1793\u2013801.","DOI":"10.1128\/MCB.18.4.1793"},{"key":"2022061700270092200_B37","doi-asserted-by":"crossref","unstructured":"Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst\u20081996; 88: 988\u201393.","DOI":"10.1093\/jnci\/88.14.988"},{"key":"2022061700270092200_B38","doi-asserted-by":"crossref","unstructured":"Harris RE, Namboodiri KK, Farrar WB. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology\u20081996; 7: 203\u20135.","DOI":"10.1097\/00001648-199603000-00017"},{"key":"2022061700270092200_B39","doi-asserted-by":"crossref","unstructured":"Parrett ML, Harris HR, Joarder FS, Ross MS, Clausen KP, Robertson FM. Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol\u20081997; 10: 503\u20137.","DOI":"10.3892\/ijo.10.3.503"},{"key":"2022061700270092200_B40","doi-asserted-by":"crossref","unstructured":"Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst\u20081998; 90: 455\u201360.","DOI":"10.1093\/jnci\/90.6.455"},{"key":"2022061700270092200_B41","doi-asserted-by":"crossref","unstructured":"Cejas P, Garcia-Cabezas MA, Casado E, et al. Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium. Clin Transl Oncol\u20082005; 7: 239\u201343.","DOI":"10.1007\/BF02710169"},{"key":"2022061700270092200_B42","doi-asserted-by":"crossref","unstructured":"Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ. Cyclooxygenase-2 is overexpressed in HER-2\/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J Biol Chem\u20082002; 277: 18649\u201357.","DOI":"10.1074\/jbc.M111415200"},{"key":"2022061700270092200_B43","unstructured":"Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res\u20082002; 62: 1676\u201381."},{"key":"2022061700270092200_B44","unstructured":"Agresti A, editor. An introduction to categorical data analysis. New York: John Wiley & Sons, Inc.; 1996."},{"key":"2022061700270092200_B45","doi-asserted-by":"crossref","unstructured":"Rigas B, Kashfi K. Cancer prevention: a new era beyond cyclooxygenase-2. J Pharmacol Exp Ther\u20082005; 314: 1\u20138.","DOI":"10.1124\/jpet.104.080564"},{"key":"2022061700270092200_B46","doi-asserted-by":"crossref","unstructured":"Denkert C, Furstenberg A, Daniel PT, et al. Induction of G0\/G1 cell cycle arrest in ovarian carcinoma cells by the anti inflammatory drug NS-398, but not by COX-2-specific RNA interference. Oncogene\u20082003; 22: 8653\u201361.","DOI":"10.1038\/sj.onc.1206920"},{"key":"2022061700270092200_B47","doi-asserted-by":"crossref","unstructured":"Palayoor ST, Arayankalayil MJ, Shoaibi A, Coleman CN. Radiation sensitivity of human carcinoma cells transfected with small interfering RNA targeted against cyclooxygenase. Clin Cancer Res\u20082005; 11: 6980\u20136.","DOI":"10.1158\/1078-0432.CCR-05-0326"},{"key":"2022061700270092200_B48","doi-asserted-by":"crossref","unstructured":"Liu CH, Chang SH, Narko K, et al. Overexpression of Cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem\u20082001; 276: 18563\u20139.","DOI":"10.1074\/jbc.M010787200"},{"key":"2022061700270092200_B49","doi-asserted-by":"crossref","unstructured":"Chang SH, Liu CH, Conway R, et al. Role of prostaglandin E2-dependent angiogenic weitch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci U S A\u20082004; 101: 591\u20136.","DOI":"10.1073\/pnas.2535911100"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/2\/467\/2597419\/467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/2\/467\/2597419\/467.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:44:27Z","timestamp":1655426667000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/2\/467\/541534\/Cyclooxygenase-2-Expression-during-Immortalization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,1,15]]},"published-print":{"date-parts":[[2008,1,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-0782","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6497744","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497744.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22375226","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22375226.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}